The efficacy of rituximab in pediatric patients with steroid-dependent or frequent relapsing nephrotic syndrome due to MCD or FSGS

BackgroundRituximab has been shown efficacy in reducing relapses among patients with steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS), primarily due to minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS). However, whether its efficacy differs between the...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Yue Xi, Ying Liang, Zhi Chen, Lei Lei, Lan Mi, Xiaoyu Tian, Liuyu Sun, Qiang Sun, Nan Zhou
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2026-04-01
سلاسل:	Frontiers in Medicine
الموضوعات:	children frequent relapsing nephrotic syndrome minimal change disease primary focal segmental glomerulosclerosis rituximab steroid-dependent nephrotic syndrome
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1763615/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!